Communicating risk reductions. Data were selectively used
- PMID: 10037654
- PMCID: PMC1115043
Communicating risk reductions. Data were selectively used
Comment on
-
Communicating the risk reduction achieved by cholesterol reducing drugs.BMJ. 1998 Jun 27;316(7149):1956-8. doi: 10.1136/bmj.316.7149.1956. BMJ. 1998. PMID: 9641937 Free PMC article. Review. No abstract available.
References
-
- The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients: the Scandinavian simvastatin survival study (4S) Lancet. 1994;344:1383–1389. - PubMed
-
- Shepherd J, Cobbe M, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease in men with hypercholesterolaemia N Engl J Med 19953331301–1307. - PubMed
-
- Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279:1615–1622. - PubMed
-
- McMurray J. Secondary prevention. London: Martin Dunitz; 1998. pp. 1–112.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources